Impax Laboratories Inc. (IPXL) Tops Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Join SI Premium – FREE
Impax Laboratories Inc. (NASDAQ: IPXL) reported Q1 adjusted EPS of $0.24, $0.09 better than the analyst estimate of $0.15. Revenue for the quarter came in at $108.7 million versus the consensus estimate of $100.21 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
- Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
- Capstone Energy+, Inc. (CEPL) Reports Q2 Loss of $0.03
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
